The plasma D-dimer trends and their value in acute lower limb ischemia patients treated by catheter directed thrombolysis

Sci Rep. 2021 May 17;11(1):10388. doi: 10.1038/s41598-021-89905-x.

Abstract

To investigate the change trends of plasma D-dimer during catheter-directed thrombolysis (CDT) in acute lower limb ischemia (ALI) patients and their clinical value. A retrospective review of patients with ALI who received CDT was carried out. The repeated measurements of plasma D-dimer were analyzed by generalized estimating equations (GEEs) and the change trends of D-dimer were analyzed by spline regression approach. A total of 150 patients were included. Among them, 3 days of CDT was ineffective in 41 cases, effective in 33 cases and markedly effective in 76 cases. The results of GEEs analysis showed that serum D-dimer changed significantly with time (time effect, P < 0.001). Serum D-dimer levels of patients with different treatment outcomes were different after treatment (group effect, P < 0.001), and serum D-dimer levels in these three groups showed different trends over time (group*time effect, P < 0.001). The different trends in serum D-dimer level with time after treatment in the three groups could be directly seen in the spline regression curve (P < 0.001). The plasma D-dimer changes regularly during CDT for ALI. We can predict the efficacy of CDT and guide adjustments of the therapeutic regimen according to the trend of D-dimer changes during thrombolysis.

MeSH terms

  • Aged
  • Arterial Occlusive Diseases / blood*
  • Arterial Occlusive Diseases / pathology
  • Arterial Occlusive Diseases / surgery
  • Arterial Occlusive Diseases / therapy
  • Catheters / adverse effects
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism*
  • Fibrinolysis / physiology
  • Humans
  • Ischemia / diagnostic imaging
  • Ischemia / pathology
  • Ischemia / surgery
  • Ischemia / therapy*
  • Lower Extremity / pathology
  • Lower Extremity / surgery
  • Male
  • Middle Aged
  • Thrombectomy
  • Thrombolytic Therapy
  • Thrombosis / diagnostic imaging
  • Thrombosis / pathology
  • Thrombosis / surgery
  • Thrombosis / therapy*
  • Treatment Outcome

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D